Incannex to Participate in the Prestigious H.C. Wainwright 24th Annual Global Investment Conference
08 sept. 2022 09h15 HE
|
Incannex Healthcare
MELBOURNE, Australia, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a pharmaceutical company developing medicinal...
Praxis Precision Medicines to Present at H.C. Wainwright 24th Annual Global Investment Conference
07 sept. 2022 16h05 HE
|
Praxis Precision Medicines, Inc.
BOSTON, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...
aTyr Pharma to Present at the H.C. Wainwright 24th Annual Global Investment Conference 2022
06 sept. 2022 08h00 HE
|
aTyr Pharma, Inc.
SAN DIEGO , Sept. 06, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
Bellicum Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
01 sept. 2022 07h30 HE
|
Bellicum Pharmaceuticals, Inc.
HOUSTON, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that Rick...
aTyr Pharma to Present at Upcoming Investor Conferences in May
10 mai 2022 08h00 HE
|
aTyr Pharma, Inc.
SAN DIEGO, May 10, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on its proprietary tRNA...
aTyr Pharma to Present at H.C. Wainwright Virtual BioConnect Conference
04 janv. 2022 08h03 HE
|
aTyr Pharma, Inc.
SAN DIEGO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological...
ObsEva to Present at the H.C. Wainwright BioConnect 2022 Conference
03 janv. 2022 07h00 HE
|
ObsEva SA
GENEVA, Switzerland January 3, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today...
ObsEva to Present at the H.C. Wainwright BioConnect 2022 Conference
03 janv. 2022 01h00 HE
|
ObsEva SA
GENEVA, Switzerland January 3, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today...
ASLAN Pharmaceuticals to Present at H.C. Wainwright 23rd Annual Global Investment Conference
09 sept. 2021 07h00 HE
|
ASLAN PHARMACEUTICALS LIMITED
MENLO PARK, Calif. and SINGAPORE, Sept. 09, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative...
Marathon Digital Holdings Sets September 2021 Conference Schedule
07 sept. 2021 16h05 HE
|
Marathon Digital Holdings, Inc.
LAS VEGAS, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Marathon Digital Holdings, Inc. (NASDAQ:MARA) ("Marathon" or "Company"), one of the largest enterprise Bitcoin self-mining companies in North America,...